Generation of adenosine A₃ receptor functionally humanized mice for the evaluation of the human antagonistsYAMANO, Kazuya; INOUE, Miho; MASAKI, Shigehiro et al.Biochemical pharmacology. 2005, Vol 71, Num 3, pp 294-306, issn 0006-2952, 13 p.Article

Type III interferon induces apoptosis in human lung cancer cellsWEI LI; XI AOJIE HUANG; ZHUOMING LIU et al.Oncology reports. 2012, Vol 28, Num 3, pp 1117-1125, issn 1021-335X, 9 p.Article

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies : Recent Progress in Gene TherapyDAVILA, Marco L; BOUHASSIRA, Diana C. G; PARK, Jae H et al.International journal of hematology. 2014, Vol 99, Num 4, pp 361-371, issn 0925-5710, 11 p.Article

Generation of CD19-chimeric antigen receptor modified CD8⁺ T cells derived from virus-specific central memory T cellsTERAKURA, Seitaro; YAMAMOTO, Tori N; GARDNER, Rebecca A et al.Blood. 2012, Vol 119, Num 1, pp 72-82, issn 0006-4971, 11 p.Article

Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010ERTL, Hildegund C. J; ZAIA, John; ROSENBERG, Steven A et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 9, pp 3175-3181, issn 0008-5472, 7 p.Article

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptorTONG ZHANG; BARBER, Amorette; SENTMAN, Charles L et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5927-5933, issn 0008-5472, 7 p.Article

Engineering T cells for cancer therapyMANSOOR, W; GILHAM, D. E; THISTLETHWAITE, F. C et al.British journal of cancer. 2005, Vol 93, Num 10, pp 1085-1091, issn 0007-0920, 7 p.Article

Reversal of antigen-dependent signaling by two mutations in antibody/receptor chimera: implication of inverse agonism in cytokine receptor superfamilyKAWAHARA, Masahiro; ISHII, Shinya; TSUMOTO, Kouhei et al.Biochemical pharmacology. 2004, Vol 68, Num 3, pp 539-548, issn 0006-2952, 10 p.Article

A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor CellsCHANG, Yu-Hsiang; CONNOLLY, John; SHIMASAKI, Noriko et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 6, pp 1777-1786, issn 0008-5472, 10 p.Article

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorHUDECEK, Michael; SCHMITT, Thomas M; WOOD, Brent et al.Blood. 2010, Vol 116, Num 22, pp 4532-4541, issn 0006-4971, 10 p.Article

Simple and highly sensitive assay system for TNFR2-mediated soluble-and transmembrane-TNF activityABE, Yasuhiro; YOSHIKAWA, Tomoaki; YOSHIOKA, Yasuo et al.Journal of immunological methods. 2008, Vol 335, Num 1-2, pp 71-78, issn 0022-1759, 8 p.Article

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRTORIKAI, Hiroki; REIK, Andreas; LEE, Dean A et al.Blood. 2012, Vol 119, Num 24, pp 5697-5705, issn 0006-4971, 9 p.Article

The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer : Progress in Pediatric CancerLEE, Daniel W; BARRETT, David M; MACKALL, Crystal et al.Clinical cancer research (Print). 2012, Vol 18, Num 10, pp 2780-2790, issn 1078-0432, 11 p.Article

Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimeraSOGO, Takahiro; KAWAHARA, Masahiro; TSUMOTO, Kouhei et al.Journal of immunological methods. 2008, Vol 337, Num 1, pp 16-23, issn 0022-1759, 8 p.Article

Growth control of hybridoma cells with an artificially induced EpoR-gp130 heterodimerKAWAHARA, Masahiro; OGO, Yuko; TSUMOTO, Kouhei et al.Cytotechnology (Dordrecht). 2006, Vol 52, Num 3, pp 171-179, issn 0920-9069, 9 p.Conference Paper

Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphomaMIHARA, Keichiro; YANAGIHARA, Kazuyoshi; KIMURA, Akiro et al.British journal of haematology. 2010, Vol 151, Num 1, pp 37-46, issn 0007-1048, 10 p.Article

Eradication of Established B-cell Lymphoma by CD19-specific Murine T Cells is Dependent on Host Lymphopenic Environment and Can be Mediated by CD4⁺ and CD8⁺ T CellsCHEADLE, Eleanor J; HAWKINS, Robert E; BATHA, Hayley et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 3, pp 207-218, issn 1524-9557, 12 p.Article

The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphomaCHEADLE, Eleanor J; GILHAM, David E; HAWKINS, Robert E et al.British journal of haematology. 2008, Vol 142, Num 1, pp 65-68, issn 0007-1048, 4 p.Article

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD 19 chimeric-antigen-receptor-transduced T cellsKOCHENDERFER, James N; DUDLEY, Mark E; YANG, James C et al.Blood. 2012, Vol 119, Num 12, pp 2709-2720, issn 0006-4971, 12 p.Article

A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cellsMCCLEMENTS, Michelle; WILLIAMS, Stella; BALL, Christine et al.Journal of immunological methods. 2008, Vol 337, Num 1, pp 63-70, issn 0022-1759, 8 p.Article

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinomaMACOR, Paolo; MEZZANZANICA, Delia; COSSETTI, Chiara et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3876-3883, issn 0008-5472, 8 p.Article

Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8⁺ Central Memory T Cells Manufactured at Clinical ScaleXIULI WANG; NARANJO, Araceli; JENSEN, Michael C et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 689-701, issn 1524-9557, 13 p.Article

IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen ExpressionCHMIELEWSKI, Markus; KOPECKY, Caroline; HOMBACH, Andreas A et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5697-5706, issn 0008-5472, 10 p.Article

Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor― Modified T CellsKONG, Seogkyoung; SENGUPTA, Sadhak; JUNGHANS, Richard P et al.Clinical cancer research (Print). 2012, Vol 18, Num 21, pp 5949-5960, issn 1078-0432, 12 p.Article

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyHOYOS, V; SAVOLDO, B; QUINTARELLI, C et al.Leukemia. 2010, Vol 24, Num 6, pp 1160-1170, issn 0887-6924, 11 p.Article